Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

This study has been completed.
Sponsor:
Collaborator:
Korea Otsuka Pharmaceutical Co.,Ltd.
Information provided by (Responsible Party):
Kyooseob Ha, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT00845988
First received: February 14, 2009
Last updated: December 4, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)